Try our Advanced Search for more refined results
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. et al
Case Number:
1:11-cv-01077
Court:
Nature of Suit:
Judge:
Firms
Companies
- Allergan PLC
- LTS Lohmann Therapie-Systeme AG
- Novartis AG
- Par Pharmaceutical Cos. Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
September 02, 2014
Judge Favors Par In Novartis Alzheimer's Patch Patent Row
A Delaware federal judge on Friday found Novartis Pharmaceuticals Corp. hadn't shown Par Pharmaceutical Inc. infringed a patent for a patch that treats Alzheimer's disease, asking the generic-name drugmaker to file a draft of a final judgment in its favor in the consolidated suit.
-
June 18, 2014
Judge Sides With Novartis In Dementia Patch Patent Row
A Delaware federal judge on Wednesday found that Watson Laboratories Inc. infringed on two of Novartis Pharmaceuticals Corp.'s patents for a patch that treats Alzheimer's disease, asking the brand-name drugmaker to file a draft of a final judgment in its favor.
-
November 04, 2011
Novartis Fights Actavis' Generic Dementia Patch
Pharmaceutical giant Novartis Pharmaceuticals Corp. lodged a patent infringement suit in Delaware on Thursday, seeking to stop Actavis Inc. from marketing a generic form of Novartis' Exelon patch used to treat dementia patients.